Biotech stocks can be incredibly attractive for risk-taking investors ... Consider when Nvidia made this list on April 15, ...

As the third-quarter earnings season ends this week, the focus in the biotech sector is mostly on pipeline and key regulatory ...

Let's consider two examples: Vertex Pharmaceuticals (NASDAQ: VRTX) and Moderna (NASDAQ: MRNA). Here's why these biotechs are ...

Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...

According to a recent article in Biospace ,"The solid tumors market size reached a value of US$ 170.3 Billion in 2023. Looking forward, the market is expected to reach US$ 375.4 Billion by 2034, ...

Case in point: Bluebird Bio is a biotech company with three approved gene-editing treatments, but its stock continues to ... Consider when Nvidia made this list on April 15, 2005 ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going to take a look at where Legend Biotech Corporation (NASDAQ:LEGN ...

Journey Medical is a partner company of Fortress Biotech Inc. (FBIO ... and reportedly carries a list price of about $3.7 million per dose. PTCT closed Tuesday's trading at $42.50, up 4.99% ...

The Women’s Edge and Globe Magazine celebrate the state’s leading companies and nonprofit organizations led by women.

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going to take a look at where Cytokinetics Inc. (NASDAQ:CYTK) stands against ...